Axa Investment Managers S.A. Astrazeneca PLC Transaction History
Axa Investment Managers S.A.
- $35.5 Billion
- Q3 2025
A detailed history of Axa Investment Managers S.A. transactions in Astrazeneca PLC stock. As of the latest transaction made, Axa Investment Managers S.A. holds 471,596 shares of AZN stock, worth $42.2 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
471,596Holding current value
$42.2 Million% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,501Shares Held
500MCall Options Held
5.64MPut Options Held
3.2M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...